Ma, Ding

Immune checkpoint therapy for solid tumours: clinical dilemmas and future trends

Sun, Q., Hong, Z., Zhang, C., Wang, L., Han, Z., & Ma, D. (2023) · Signal Transduction and Targeted Therapy

Cancer Immunotherapy and BiomarkersImmunotherapy and Immune Responses

Cited by 598

ARID1A deficiency promotes mutability and potentiates therapeutic antitumor immunity unleashed by immune checkpoint blockade

Shen, J., Ju, Z., Zhao, W., Wang, L., Peng, Y., Ge, Z., Nagel, Z. D., Zou, J., Wang, C., Kapoor, P., et al. (2018) · Nature Medicine

Chromatin Remodeling and CancerCancer Immunotherapy and Biomarkers

Cited by 562

The microbial metabolite trimethylamine N-oxide promotes antitumor immunity in triple-negative breast cancer

Wang, H., Rong, X., Zhao, G., Zhou, Y., Xiao, Y., Ma, D., Jin, X., Wu, Y., Yan, Y., Yang, H., et al. (2022) · Cell Metabolism

Cancer Immunotherapy and BiomarkersGut microbiota and health

Cited by 411

Technological advances in cancer immunity: from immunogenomics to single‐cell analysis and artificial intelligence

Xu, Y., Su, G.-H., Ma, D., Xiao, Y., Shao, Z.-M., & Jiang, Y.-Z. (2021) · Signal Transduction and Targeted Therapy

Cancer Immunotherapy and BiomarkersSingle-cell and spatial transcriptomics

Cited by 163

Targeting SphK2 reverses acquired resistance of Regorafenib in hepatocellular carcinoma

Shi, W., Zhang, S., Ma, D., Yan, D., Zhang, G., Cao, Y., Wang, Z., Wu, J., & Jiang, C. (2020) · Frontiers in Oncology

Sphingolipid Metabolism and SignalingHepatocellular Carcinoma Treatment and Prognosis

Cited by 61